Bontia Bio raises NZ$1.25M to develop safer, plant-based flea and tick treatments for pets.

Bontia Bio, a New Zealand biotech firm, has raised NZ$1.25 million to develop a new flea and tick treatment for pets using natural compounds from plants. The funding, led by Sprout Agritech, will help the company produce these compounds through a new microbial fermentation process, offering a safer and more sustainable alternative to existing treatments. The technology could also have broader applications in agriculture.